Loading…
psoriasis
chronic autoimmune skin condition causing scaly red plaques
Details
- Instance of
- type of disease, symptom or sign
- Subclass of
- autoimmune skin disease
- described by source
- Granat Encyclopedic Dictionary, Brockhaus and Efron Encyclopedic Dictionary, Small Brockhaus and Efron Encyclopedic Dictionary, Encyclopædia Britannica 11th edition, Armenian Soviet Encyclopedia, vol. 9
- drug or therapy used for treatment
- methotrexate, non-steroidal anti-inflammatory drug, tazarotene, ethyl fumarate, desoximetasone, apremilast, tacalcitol, calcipotriene, desonide
- genetic association
- ZMIZ1, SOCS1, CAPZB, ZDHHC23, TYK2, IL23R, IL12B, TNFAIP3, NOS2, IL13, TSC1, COG6
- health specialty
- dermatology
- ICPC 2 ID
- S91
- possible treatment
- ultraviolet light therapy
- risk factor
- smoking, stress, obesity, Xerosis cutis
- symptoms and signs
- itch, arthritis, inflammation, desquamation
- topic's main category
- Category:Psoriasis
Connected on Wikidata
Subject of
- World Psoriasis Day
- 1911 Encyclopædia Britannica/Psoriasis
- Study of Efficacy and Safety of Brodalumab Compared With Placebo and Ustekinumab in Moderate to Severe Plaque Psoriasis Subjects
- Study of Efficacy, Safety, and Withdrawal and Retreatment With Brodalumab (AMG 827) in Moderate to Severe Plaque Psoriasis Subjects
- Serum Granulysin Level as a Marker to Detect the Severity of Psoriasis
- An Efficacy and Safety of Guselkumab in Participants With Palmoplantar Pustulosis
- Ustekinumab Safety and Surveillance Program Using the Ingenix NHI Database
- LEO 90100 Aerosol Foam Compared to Calcipotriol Plus Betamethasone Dipropionate Gel in Subjects With Psoriasis Vulgaris
- DFD06 Cream vs Clobetasol Propionate Cream, 0.05% Hypothalamic- Pituitary-Adrenal (HPA) Axis Suppression Study in Patients With Moderate to Severe Plaque Psoriasis
- Efficacy and Safety of Namilumab (MT203) for Plaque Psoriasis
Nothing in the MetaHistoryBook collection references this item yet.